CAD software for synthetic biology
Computer-aided design software that lets a synthetic biologist draft a genetic construct, simulate its behavior and generate an assembly protocol before a single base pair is synthesized — the digital design layer upstream of both the wet-lab gene-synthesis foundries and the strain-engineering CROs already covered on this site, borrowing the electronic-design-automation model from semiconductor chip design.
1 · What it gives
CAD software for synthetic biology applies the electronic-design-automation model from semiconductor chip design to genetic engineering: a biologist drafts a genetic construct in software, simulates how the design will behave, and generates an assembly protocol — all before committing to physical DNA synthesis. One platform’s patented machine-learning engine closes design-build-test-learn cycles ten times faster than random screening; another traces its core technology to Cello, a hybrid genetic-engineering and CAD platform originally built to program logic circuits directly into living cells. This is the digital design layer that sits upstream of both the commercial gene-synthesis foundries and the strain-engineering contract research organizations already covered on this site — the software drafts and simulates the construct, the foundry physically synthesizes it, and the CRO engineers the resulting strain, three distinct stages with three distinct vendor sets.
Key directions of CAD software for synthetic biology:
- BioCAD/CAM platforms (BioCAD/CAM Platform): integrated design, simulation and assembly-protocol-generation software spanning the full design-build cycle for a genetic construct.
- Design-build-test-learn automation (DBTL Automation): machine-learning and AI-agent tooling that closes the iterative cycle of designing, building, testing and refining a biological system faster than traditional screening.
- Custom bespoke software development (Bespoke Synbio Software): software studios that embed with biotech companies to build internal design tools and workflow software rather than selling a one-size-fits-all product.
- Genetic part and circuit simulation (Genetic Part Simulation): simulation engines that predict how a genetic circuit or part will behave in a target cell type before physical construction.
Sectoral value chain#
[genetic construct drafting] ──> [behavior simulation] ──> [assembly protocol generation] ──> [DBTL iteration]
│
(physical synthesis handoff)
│
▼
[optimized genetic design] <─── [experimental data feedback] <──┘
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Construct drafting | designing a genetic sequence or circuit in software | In: design intent, genetic-part library. Out: draft construct design. |
| Behavior simulation | predicting how the design will function in a target cell | In: draft construct, host-organism model. Out: simulated behavior prediction. |
| Assembly protocol generation | generating the physical lab protocol to build the construct | In: finalized design. Out: assembly protocol (e.g. Gibson, Golden Gate). |
| Physical synthesis handoff | protocol transferred to a gene-synthesis foundry or in-house lab | In: assembly protocol. Out: synthesized physical construct. |
| Experimental data feedback | test results fed back into the design platform | In: lab/assay results. Out: structured data for the next design cycle. |
| DBTL iteration | refining the design based on experimental data | In: experimental feedback. Out: optimized next-generation design. |
Cross-cutting technologies:
- BioCAD/CAM platform (BioCAD/CAM Platform): integrated software spanning genetic design, simulation and protocol generation.
- DBTL automation (Design-Build-Test-Learn Automation): ML/AI tooling accelerating iterative biological design cycles.
- Genetic part simulation (Genetic Part Simulation): predictive modeling of genetic circuit behavior before physical construction.
2 · What it replaces 3 · matched by industry
| D3E– | Agricultural spraying drones instead of knapsack and manned aerial spraying Replaces: Manual knapsack spraying, tractor spraying in small or wet fields, and manned aircraft/helicopter spraying | EAC |
| D2E– | Drone release of beneficial insects (Trichogramma, Cotesia, predatory mites) instead of insecticide sprays Replaces: Insecticide sprays against caterpillar and mite pests, and manual walking release of natural enemies (the labour bottleneck of large-scale … | MACRO |
| D3E2 | Genomic selection in dairy cattle breeding instead of progeny testing Replaces: Progeny testing — choosing AI bulls only after their daughters' milk records were available (5–6 years per bull and large testing costs) | BREED |
3 · How to implement 6 steps
- 1Design intent captureThe biologist specifies the desired function of the genetic construct — what behavior or output the design should produce in the target host cell.
- 2Construct draftingTesting & analyticsThe software assembles a candidate genetic sequence or circuit from a library of characterized genetic parts, matching the specified design intent.Who can do this step matched automaticallyFastBio Brazil“Com forte networking e com parcerias estabelecidas junto as principais Contract Research Organizations (CROs), a FastBio disponibiliza um portfolio de serviços biológicos …”Turion Labs Singapore“Turion Labs is a Singapore-headquartered biotech innovation platform that provides shared laboratory infrastructure, contract research organization (CRO) services, and regulatory …”
- 3Behavior simulationA simulation engine predicts how the drafted construct will behave in the target cell type, flagging likely failure modes before any physical synthesis is committed to.
- 4Protocol generationThe platform generates the physical lab assembly protocol — a Gibson assembly, Golden Gate cloning or similar method — needed to build the finalized construct.
- 5Physical synthesis handoffSynthesis & conversionThe generated protocol and construct design are handed off to a gene-synthesis foundry or in-house lab for physical construction.Who can do this step matched automaticallyBota Bio 恩和生物 China✓ ISO 9001 600 tons pilot scale“Protein expression is limited by multiple bottlenecks, such as transcription efficiency, translation efficiency, metabolic constraints, protein folding, and hydrolysis.”163,050 tonnes“Uniquely equipped with the credentials for the R&D, design, and production of both high-efficiency dust filtration materials and SCR denitration catalysts, as well as for the …”
- 6Data feedback and DBTL iterationExperimental results from the physically built and tested construct are fed back into the design platform, closing the design-build-test-learn loop and informing the next design iteration.
4 · Who delivers
Matched suppliers (matched automatically)
| Liying Biotech 粒影生物 | China | Producer | active |
| Caladan Bio | United States | Producer | active |
| Tsingke Biotechnology | China | Producer | active |
| Dassault Systemes | France | Producer | active |
| BIONET | Spain | Equipment | active |
| PUEVIT GmbH | Germany | Equipment | active |
| Shengquan Group | China | Producer | active |
| Paris Biofoundry (France) | France | Research / RTO | active |
| Bluepha 蓝晶微生物 | China | Producer | active |
| Bota Bio 恩和生物 | China | Producer | active |
| Shanghai/SIAT SynBio foundries (China) | China | Producer | active |
In the services and supply catalogue 1 · paid service
Process modelling & simulation
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| TeselaGen | 🇺🇸 USA | BioCAD/CAM platform, Synthetic Evolution® | Patented ML engine closes DBTL cycles 10x faster than random screening; AI design agents | Commercial |
| Lattice Automation | 🇺🇸 USA | Custom synbio software development | Embeds with biotech teams to build bespoke internal design tools | Commercial |
| Synthace | 🇬🇧 UK | Digital Experiment Platform (Antha®) | Cloud-based DOE automation; validated by AstraZeneca, GSK, Charles River | Commercial |
| Asimov | 🇺🇸 USA | CAD platform built on the Cello genetic-circuit system | Cloud-based design/simulation across cell types; DARPA-funded AI design engine research | Commercial |
5 · Rules & route to market
declaration registered within 3 working days (testing extra); certification longer
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The US hosts the category’s most established and most heavily funded platforms, spanning an AI-native design-automation company, a bespoke software studio, and a CAD platform that originated as an academic logic-circuit-programming tool.
AI-accelerated DBTL platforms, bespoke embedded software studios, academic-to-commercial CAD lineage#
- TeselaGen (founded 2013): offers a BioCAD/CAM platform built around Synthetic Evolution®, a patented machine-learning engine the company states closes design-build-test-learn cycles ten times faster than random screening, alongside AI agents for library design and sequence optimization.
- Lattice Automation: a life-sciences software development studio that embeds with biotech teams to build custom internal design tools and workflow software rather than selling a single standardized product.
- Asimov’s CAD platform: co-founded in 2017 by the MIT professor behind Cello, a hybrid genetic-engineering/CAD system originally built to program logic-circuit behaviors into living cells, now offered as cloud-based software to design, simulate and optimize genetic systems across cell types.
European Union
The UK hosts a design-of-experiments software pioneer that pivoted from wet-lab synthetic biology into pure software, now validated by major pharmaceutical companies.
academic spinout to pure-software pivot, design-of-experiments automation, pharma-validated platform#
- Synthace (London, founded 2011): a University College London spinout that operated as a synthetic biology company before pivoting fully to software in 2017; its cloud-based Digital Experiment Platform automates design-of-experiments for complex biological processes, validated by AstraZeneca, GSK and Charles River.
- EU AI Act context: as CAD platforms increasingly embed machine-learning design-automation features, general-purpose AI model obligations under the EU AI Act are an emerging compliance consideration for European synbio-software vendors specifically.
- Recognition track record: Synthace was named a World Economic Forum Technology Pioneer in 2016 and a Gartner Cool Vendor in Life Sciences in 2018, external validation markers for a category where commercial traction can otherwise be hard to verify independently.
China
No confirmed Chinese commercial CAD-for-synthetic-biology vendor was found; Chinese activity in this space is concentrated in academic and student competition projects rather than standalone commercial software products.
academic and iGEM-competition tool development, no confirmed commercial vendor, broader synbio manufacturing capacity elsewhere#
- iGEM student competition tools: Chinese university teams have built award-winning genetic-circuit-design software (gene-circuit visual analytics, computer-aided synbio design tools) through the international iGEM synthetic-biology competition, demonstrating strong academic capability without a confirmed spinout into standalone commercial software.
- No confirmed specialist producer: searches for a mainland commercial BioCAD vendor returned only academic and open-source tools — left qualitative pending a real commercial candidate.
- Broader synbio capacity context: China’s substantial gene-synthesis and strain-engineering manufacturing capacity, covered elsewhere on this site, has not yet produced a confirmed standalone commercial design-software export comparable to the US platforms.
6 · Money: tenders & grants
| Grant | Circular innovative advanced materials: facilitating the transition from design to markets (RIA) (Innovative … European Commission · EU | Feb 2, 2027 71 days |
| Grant | Increasing the resilience of agriculture in water and nutrient-scarce environments through digital innovations European Commission · EU | Sep 23, 2027 304 days |
7 · Tech stack & innovations
The category borrows its core methodology from semiconductor electronic design automation, adapted to the added complexity of biological systems that don’t behave with silicon’s predictability.
- Machine-learning-accelerated DBTL cycling (ML-Driven Design
Iteration):
- Patented ML engines learn from each round of experimental results to propose the next design iteration more efficiently than exhaustive or random screening, the core mechanism behind claimed order-of-magnitude speedups in design cycles.
- AI agents increasingly handle specific sub-tasks within the cycle — library design, sequence optimization — rather than the platform being a single monolithic tool.
- Genetic circuit and part simulation (Predictive Behavior Modeling):
- Simulation engines predict how a genetic circuit will behave in a specific host cell type before physical construction, the capability that originated in academic logic-circuit-programming research before being commercialized.
- Simulation accuracy depends on the quality and breadth of the underlying genetic-part behavior library, making part-library curation as important as the simulation algorithm itself.
- Cloud-based design-of-experiments automation (DOE Platform
Architecture):
- Cloud platforms let a biologist design multivariate experiments, simulate them digitally, execute them on connected lab hardware and receive structured, AI-ready data — a no-code workflow bridging digital design and physical lab execution.
- This architecture is what lets a platform originally built by synthetic biologists for their own use pivot into a standalone software product sold to other biotech companies.
Sources 4 · 0 independent · 4 producer sites
Producers' own sites 4
- Teselagen producer checked 2026-08-11 · link not kept
- Lattice automation producer checked 2026-08-11 · link not kept
- Synthace producer checked 2026-08-11 · link not kept
- Asimov producer checked 2026-08-11 · link not kept